Cost-effectiveness of the use of the continuous subcutaneous insulin infusion pump versus daily multiple injections in type 1 diabetes adult patients at the Mexican Institute of Social Security

Table 6 Projected time free of complications as estimated using a cohort of IMSS adult patients with T1D

	CSII (years)	MDI (years)	Absolute difference (years)
Any complications	1.12	0.73	0.39
Background retinopathy	7.1	4.86	2.24
Proliferative retinopathy	18.74	16.18	2.56
Microalbuminuria	8.09	6.13	1.96
Gross proteinuria	18.89	16.07	2.82
End-stage renal disease	23.75	21.13	2.62
First ulcer	18.3	15.22	3.08
Amputation	22.83	20.19	2.64
Neuropathy	10.43	7.72	2.71
Peripheral vascular disease	23.41	21	2.41
Congestive heart failure	23.97	21.4	2.57
Angina	23.72	21.26	2.46
Myocardial infarction	24.21	21.75	2.46
Stroke	23.77	21.47	2.3
Cataract	21.46	19.54	1.92

ISSN: 1478-7547